Tadashi Ogawa Selected Research

Tadashi Ogawa Research Topics

4	Neoplasms (Cancer) 07/2011 - 08/2002
3	Rectal Neoplasms (Rectal Cancer) 01/2018 - 03/2015
3	Neoplasm Metastasis (Metastasis) 01/2017 - 07/2011
2	Acute Cholecystitis 07/2020 - 01/2012
2	Inflammation (Inflammations) 01/2020 - 01/2005
2	Carcinoma (Carcinomatosis) 01/2018 - 01/2011
2	Non-alcoholic Fatty Liver Disease 02/2013 - 06/2005
2	Stroke (Strokes) 02/2013 - 03/2008
2	Hyperinsulinism (Hyperinsulinemia) 02/2004 - 08/2003
2	Hyperglycemia 02/2004 - 08/2003
1	Dementia (Dementias) 07/2020
1	Cholecystitis 07/2020
1	Cholelithiasis 07/2020
1	Hernia (Hernias) 06/2020
1	Diarrhea 01/2020
1	Dysbiosis 01/2020
1	Ascites 03/2019
1	Internal Hernia 03/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Overactive Urinary Bladder (Overactive Bladder) 01/2017
1	Testicular Neoplasms (Testicular Cancer) 01/2017
1	Hemangioma (Angioma) 12/2013
1	Diaphragmatic Hernia 12/2013
1	Thrombosis (Thrombus) 11/2011
1	Idiopathic Noncirrhotic Portal Hypertension 11/2011
1	Varicose Veins (Varicose Vein) 11/2011
1	Hemorrhage 11/2011
1	Breast Neoplasms (Breast Cancer) 07/2011
1	Bile Duct Neoplasms (Bile Duct Cancer) 03/2011
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 06/2005
1	Hypertriglyceridemia 02/2004
1	Atherosclerosis 02/2004
1	Obesity 08/2003
1	Insulin Resistance 08/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2002
1	Lung Neoplasms (Lung Cancer) 08/2002

2	LipidsIBA 01/2020 - 06/2005
1	Polypropylenes (Polypropylene)IBA 06/2020
1	palmitoleic acidIBA 01/2020
1	protectin D1IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	silodosin FDA Link 01/2017
1	naftopidilIBA 01/2017
1	AntigensIBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 04/2016
1	Bile Acids and Salts (Bile Acids)IBA 02/2013
1	CholesterolIBA 02/2013
1	Mitogen-Activated Protein KinasesIBA 03/2011
1	Peptide Hydrolases (Proteases)FDA Link 03/2011
1	NF-kappa B (NF-kB)IBA 03/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2011
1	N-valyltryptophanIBA 03/2008
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2005
1	Amino Acids FDA Link 01/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2005
1	Dietary ProteinsIBA 02/2004
1	Proteins (Proteins, Gene)FDA Link 02/2004
1	AcidsIBA 02/2004
1	Interleukin-12 (IL 12)IBA 02/2004
1	4-(2-pyridyldithio)butyramidineIBA 02/2004
1	Glycine max beta-conglycinin proteinIBA 02/2004
1	Hormones (Hormone)IBA 08/2003
1	EnzymesIBA 08/2003
1	ImmunosorbentsIBA 08/2003
1	ResistinIBA 08/2003
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2002
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2002
1	Angiopoietin-1IBA 08/2002

3	Therapeutics 07/2011 - 08/2002
2	Laparotomy 07/2020 - 03/2019
2	Laparoscopic Cholecystectomy 07/2020 - 01/2012
2	Lymph Node Excision (Lymph Node Dissection) 03/2019 - 03/2015
2	Neoadjuvant Therapy 01/2018 - 01/2011
2	Radiotherapy 01/2018 - 04/2016
2	Chemoradiotherapy 01/2018 - 04/2016
1	Length of Stay 07/2020
1	Surgical Instruments (Clip) 06/2020
1	Prostatectomy (Retropubic Prostatectomy) 03/2019
1	Hepatectomy 12/2013
1	Splenectomy 11/2011
1	Drug Therapy (Chemotherapy) 07/2011
1	Oral Administration 03/2008